Skip to main content
Steven Schachter, MD, Neurology, Boston, MA, Beth Israel Deaconess Medical Center

StevenCSchachterMD

Neurology • Boston, MA

Neurophysiology

Professor of Neurology, Beth Israel Deaconess Medical Center

Join to view full profile

Are you Dr. Schachter?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 32 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Steven Schachter, MD is a board certified neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts. He is affiliated with Beth Israel Deaconess Medical Center and is a Professor of Neurology at Beth Israel Deaconess Medical Center.

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1981 - 1984
  • University of North Carolina Hospitals
    University of North Carolina HospitalsInternship, Internal Medicine, 1980 - 1981
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1980

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1982 - 2023
  • American Board of Psychiatry and Neurology Neurology

Publications & Presentations

PubMed

Press Mentions

  • NIH MedTech Program Aims to Accelerate Medical Devices to Treat, Diagnose Nervous System Disorders
    NIH MedTech Program Aims to Accelerate Medical Devices to Treat, Diagnose Nervous System DisordersNovember 21st, 2022
  • LivaNova VNS Therapy System for Drug-Resistant Epilepsy Could Save $77,000 Per Patient over Five Years
    LivaNova VNS Therapy System for Drug-Resistant Epilepsy Could Save $77,000 Per Patient over Five YearsSeptember 4th, 2018
  • LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment for Drug-Resistant Epilepsy Patients
    LivaNova Launches Global Clinical Registry to Assess VNS Therapy Treatment for Drug-Resistant Epilepsy PatientsAugust 24th, 2018
  • Join now to see all

Grant Support

  • Feasibility Of A Combined Seizure Detector-Vns SystemNational Center For Research Resources2008
  • Remacemide As Monotherapy In Partial Onset SeizuresNational Center For Research Resources2000–2002
  • Trial Of Gp47779 (Nhd Of Oxcarbazepine) Administered IV To InpatientsNational Center For Research Resources1999–2002
  • Losigamone As Monotherapy In Treatment Of Complex Partial SeizuresNational Center For Research Resources1999–2002
  • Extension Trial Of Oxcarbazepine In Patients W/ Partial SeizuresNational Center For Research Resources1999–2002
  • Pregabalin OPEN Label, Follow On Safety Trial In Patients W/ EpilepsyNational Center For Research Resources1999–2000
  • Pregabalin In Patient Monotherapy Trial In Patients W/ EpilepsyNational Center For Research Resources1999–2000
  • Losigamone In Treatment Of Complex Childrens HospitalNational Institute Of Neurological Disorders And Stroke1998–2000
  • Evaluation Of ADD On 534u87 Treatment Of Partial SeizuresNational Center For Research Resources1998–2000
  • Trial Of Oxcarbazepine In Patients With Partial SeizuresNational Center For Research Resources1996–1999
  • Losigamone As Monotherapy For Complex Partial SeizuresNational Institute Of Neurological Disorders And Stroke1997
  • Remacemide Inpatient Seizure Evaluation TrialNational Center For Research Resources1997
  • Vagus Nerve Stimulation For Adjunctive Treatment Of EpilepsyNational Center For Research Resources1996–1997

Hospital Affiliations

Dr. Steven Schachter, Dr. Steven Schachter, MD, Dr. S Schachter, Dr. Steven C Schachter